Moore Susan, Mills Benjie B, Moore Robert D, Miklos John R, Mattox Thomas Fleming
Center for Women's Medicine, Greenville Hospital System, SC 29605, USA.
Am J Obstet Gynecol. 2005 May;192(5):1718-21. doi: 10.1016/j.ajog.2004.11.048.
The purpose of this study was to determine if a perisurgical smoking cessation program reduces smoking-related postoperative complications in urogynecologic surgery.
A review of patients that underwent pelvic reconstructive surgery from 1998 to 2003 was performed. All smokers underwent a perisurgical smoking cessation program of their choice for at least 1 month before surgery, and continued for 1 month after surgery. Complications unrelated to smoking (cystotomy, enterotomy, urethral obstruction, etc) were excluded in the smoking-potentiated complications. Problems considered to be potentiated by smoking were: wound, pulmonary, cardiac, and febrile morbidity.
Eight hundred eighty-seven patients were included. There were 233 smoker cessation patients (SC) and 654 nonsmokers (NS). The total number of complications in the SC group was 61 (61/233, 26%) compared with 172 (172/654, 29%) in the NS group: (chi-square, P = .97). When looking at smoking-potentiated complications only, there were 34 (34/61, 56%) patients in the SC group and 90 (90/172, 52%) in the NS group (chi-square, P = .75).
There are no differences in smoking-potentiated complications between nonsmoking patients and patients who undergo a perisurgical smoking cessation program.
本研究旨在确定围手术期戒烟计划是否能降低泌尿妇科手术中与吸烟相关的术后并发症。
对1998年至2003年接受盆腔重建手术的患者进行回顾性研究。所有吸烟者在手术前至少1个月接受其选择的围手术期戒烟计划，并在术后持续1个月。在吸烟加剧的并发症中排除与吸烟无关的并发症（膀胱切开术、肠切开术、尿道梗阻等）。被认为因吸烟而加剧的问题包括：伤口、肺部、心脏和发热性疾病。
共纳入887例患者。其中有233例戒烟患者（SC）和654例非吸烟者（NS）。SC组的并发症总数为61例（61/233，26%），而NS组为172例（172/654，29%）：（卡方检验，P = 0.97）。仅观察吸烟加剧的并发症时，SC组有34例（34/61，56%）患者，NS组有90例（90/172，52%）患者（卡方检验，P = 0.75）。
非吸烟患者与接受围手术期戒烟计划的患者在吸烟加剧的并发症方面没有差异。
